231 related articles for article (PubMed ID: 31051312)
1. A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model.
El-Ashmawy NE; El-Zamarany EA; Salem ML; Khedr EG; Ibrahim AO
Mol Immunol; 2019 Jul; 111():106-117. PubMed ID: 31051312
[TBL] [Abstract][Full Text] [Related]
2. Dual-targeted therapeutic strategy combining CSC-DC-based vaccine and cisplatin overcomes chemo-resistance in experimental mice model.
El-Ashmawy NE; Salem ML; Khedr EG; El-Zamarany EA; Ibrahim AO
Clin Transl Oncol; 2020 Jul; 22(7):1155-1165. PubMed ID: 31748959
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses.
Dashti A; Ebrahimi M; Hadjati J; Memarnejadian A; Moazzeni SM
Cancer Lett; 2016 Apr; 374(1):175-185. PubMed ID: 26803056
[TBL] [Abstract][Full Text] [Related]
4. Synergistic combination of murine bone marrow-derived dendritic cells loaded ex vivo with whole tumor lysate and systemic chemotherapy mediates antitumor immune responses in vivo.
Salem ML; Nassef M; Gomaa S; Essa I
Biomed Pharmacother; 2017 Sep; 93():286-295. PubMed ID: 28648976
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study.
El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
Clin Exp Med; 2018 Nov; 18(4):535-546. PubMed ID: 30062618
[TBL] [Abstract][Full Text] [Related]
6. Targeting CD166
El-Ashmawy NE; Salem ML; Abd El-Fattah EE; Khedr EG
Toxicol Appl Pharmacol; 2021 Oct; 429():115699. PubMed ID: 34437932
[TBL] [Abstract][Full Text] [Related]
7. Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.
Li X; Zhang Z; Lin G; Gao Y; Yan Z; Yin H; Sun B; Wang F; Zhang H; Chen H; Cao D
Tumour Biol; 2016 Aug; 37(8):11267-78. PubMed ID: 26951511
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Antitumor Efficacy of Cancer Stem Cell-Derived DRibble Vaccine on Colorectal Carcinoma.
Fu C; Tian G; Duan J; Liu K; Zhang C; Yan W; Wang Y
Int J Med Sci; 2021; 18(14):3249-3260. PubMed ID: 34400894
[TBL] [Abstract][Full Text] [Related]
9. "Double hit" strategy: Removal of sialic acid from the dendritic cell surface and loading with CD44+/CD24-/low cell lysate inhibits tumor growth and metastasis by targeting breast cancer stem cells.
Acikgoz E; Duzagac F; Guven U; Yigitturk G; Kose T; Oktem G
Int Immunopharmacol; 2022 Jun; 107():108684. PubMed ID: 35272171
[TBL] [Abstract][Full Text] [Related]
10. Effective tumor immunity to melanoma mediated by B16F10 cancer stem cell vaccine.
Zhao F; Zhang R; Wang J; Wu D; Pan M; Li M; Guo M; Dou J
Int Immunopharmacol; 2017 Nov; 52():238-244. PubMed ID: 28950176
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.
Xu Q; Liu G; Yuan X; Xu M; Wang H; Ji J; Konda B; Black KL; Yu JS
Stem Cells; 2009 Aug; 27(8):1734-40. PubMed ID: 19536809
[TBL] [Abstract][Full Text] [Related]
12. Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.
Ruan S; Lin M; Zhu Y; Lum L; Thakur A; Jin R; Shao W; Zhang Y; Hu Y; Huang S; Hurt EM; Chang AE; Wicha MS; Li Q
Cancer Res; 2020 Feb; 80(4):771-783. PubMed ID: 31843981
[TBL] [Abstract][Full Text] [Related]
13. A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties.
Mahmoodi S; Nezafat N; Negahdaripour M; Ghasemi Y
Curr Mol Med; 2019; 19(1):2-11. PubMed ID: 30714514
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
15. Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.
Wu D; Wang J; Cai Y; Ren M; Zhang Y; Shi F; Zhao F; He X; Pan M; Yan C; Dou J
J Ovarian Res; 2015 Oct; 8():68. PubMed ID: 26497895
[TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model.
Zheng F; Dang J; Zhang H; Xu F; Ba D; Zhang B; Cheng F; Chang AE; Wicha MS; Li Q
J Immunother; 2018 Oct; 41(8):361-368. PubMed ID: 30063587
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells loaded with exosomes derived from cancer stem cell-enriched spheroids as a potential immunotherapeutic option.
Naseri M; Zöller M; Hadjati J; Ghods R; Ranaei Pirmardan E; Kiani J; Eini L; Bozorgmehr M; Madjd Z
J Cell Mol Med; 2021 Apr; 25(7):3312-3326. PubMed ID: 33634564
[TBL] [Abstract][Full Text] [Related]
18. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
Kawano M; Itonaga I; Iwasaki T; Tsumura H
Oncol Rep; 2013 Mar; 29(3):1001-6. PubMed ID: 23291864
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of cisplatin resistant bladder tumor by combination of cisplatin treatment and co-culture of dendritic cells with apoptotic bladder cancer cells.
Zhang Q; Chen Z
Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):102-107. PubMed ID: 30084800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
